The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

The move, which is intended to make sure jabs such as Wegovy or Mounjaro are prescribed ... Weight-loss drugs have also now been added to the list of “high-risk” medicines requiring extra ...

Some information was provided starting in January, but it is still inadequate,” the United Food & Commercial Workers Union Local 7 said. Meanwhile, the grocer said in a statement on Friday that ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as ...

Last month, Ozempic and Wegovy were listed along another diabetes drug, Rybelsus, as part of the list of 15 drugs last month. But how the new Trump administration will handle the negotiations ...

The company's blockbuster semaglutide drugs, Wegovy for weight loss and Ozempic ... The semaglutide drugs are also still on the FDA's shortage list, which means compounding pharmacies are still ...